|
#1
10.05.2008, 12:07
|
|||
|
|||
|
Guidelines ïî îôòàëüìîëîãèè
Ñ÷èòàþ, ÷òî â ñâîåé ðàáîòå âåñüìà ïîëåçíî îáðàùàòüñÿ ê ìåæäóíàðîäíîìó îïûòó â ëå÷åíèè ãëàçíûõ áîëåçíåé.
Guidelines ïî îôòàëüìîëîãèè ICO International Clinical Guidelines: [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Age-related Macular Degeneration (Initial and follow-up evaluation) Age-Related Macular Degeneration (Management recommendations) Amblyopia (Initial and follow-up evaluation) Bacterial Keratitis (Initial evaluation) Bacterial Keratitis (Management recommendations) Blepharitis (Initial and follow-up evaluation) Cataract (Initial evaluation) Conjunctivitis (Initial evaluation) Dry Eye (Initial evaluation) Diabetic Retinopathy (Initial and follow-up evaluation) Diabetic Retinopathy (Management recommendations) Esotropia (Initial and follow-up evaluation) Eye Disease in Leprosy (Initial evaluation and management) Posterior Vitreous Detachment, Retinal Breaks and Lattice Degeneration (Initial and follow-up evaluation) Primary Angle Closure (Initial evaluation) Primary Open-Angle Glaucoma (Initial evaluation) Primary Open-Angle Glaucoma (Follow-up evaluation) Primary Open-Angle Glaucoma Suspect (Initial and follow-up evaluation) Trachoma 
|
|
#4
15.09.2009, 23:24
|
|||
|
|||
|
Êðàòêî - î ãëàóêîìå: [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Öèòàòà:
Öèòàòà:
|
|
#6
27.11.2010, 16:26
|
|||
|
|||
|
×òîáû ÷åðåç äâà ãîäà ñîõðàíèëîñü íå èçìåíåííûì? Òàê íå áûâàåò. Ìîæíî ïîïðîáîâàòü òàê: [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
È òàì ïîèñêàòü ÷òî òðåáóåòñÿ. Íàïðèìåð ïåðâûé æå òîïèê èç ñïèñêà: [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
|
|
#9
28.02.2018, 11:06
|
||||
|
||||
|
Öèòàòà:
|
|
#10
18.09.2022, 21:13
|
|||
|
|||
|
Õåðø Îôòëüìîõèðóðãèÿ
Çäðàâñòâóéòå! Ìîæåò ó êîãäà íèáóäü åñòü ññûëêà äëÿ ñêà÷èâàíèÿ êíèãè Õåðø" Îôòàëüìîõèðóðãèÿ" áûëà áû î÷åíü ïðèçíàòíëüíà
|
Ëèíåéíûé âèä
